Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metformin Continuation Safety in Diabetic Patients Undergoing Coronary Angiography

NCT04766008 is registered in ClinicalTrials.gov with Humanitas Hospital, Italy as lead sponsor.

NCT NCT04766008
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04766008 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metformin Continuation Safety in Diabetic Patients Undergoing Coronary Angiography
Lead sponsor
Humanitas Hospital, Italy
Phase
Phase 4
Overall status
Unknown status
Start date
January 15, 2020
Completion date
April 30, 2022
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

contrast-induced nephropathy, coronary artery disease, diabetes mellitus, lactic acidosis with diabetes mellitus, metformin associated lactic acidosis